As EZH2 can regulate MYC expression at the transcriptional level or promote MYC stabilization as a non‐PRC2 partner in several tumors,[9, 13] this prompted us to examine whether squamocin treatment also affected EZH2 levels in two HNSCC cell lines. The gene discussed is EZH2; the disease is head and neck squamous cell carcinoma.